Tesaro update

As of November 29, 2014, Tesaro had published a poster for ECCO 2014.

40 patients in trial. 20 with NSCLC. 13 ALK +. 9 previously treated with Crizotinib. 4 partial responses.

http://www.tesarobio.com/documents/TSR_011_EORTC_2014.pdf

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply